Which has better earnings & valuation, BACK or IMAC?

IMAC has higher earnings, but lower revenue than IMAC. IMAC is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $72.05K 0.03 -$9.42M -$3.12 N/A IMAC $15.22M 0.00 -$10.54M -$0.27 N/A

Is BACK or IMAC more profitable?

IMAC has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets IMAC N/A N/A -325.44% IMAC -75.40% -52.17% -34.51%

Does the media refer more to BACK or IMAC?

In the previous week, IMAC had 4 more articles in the media than IMAC. MarketBeat recorded 6 mentions for IMAC and 2 mentions for IMAC. IMAC's average media sentiment score of 0.42 beat IMAC's score of 0.10 indicating that IMAC is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IMAC 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IMAC 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, IMAC or AONCW?

American Oncology Network has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $15.22M 0.00 -$10.54M -$0.27 N/A American Oncology Network $1.34B N/A N/A N/A N/A

Do analysts rate IMAC or BTSGU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 BrightSpring Health Services 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, IMAC or BTSGU?

BrightSpring Health Services has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $15.22M 0.00 -$10.54M -$0.27 N/A BrightSpring Health Services $14.37B N/A N/A N/A N/A

Does the media refer more to IMAC or BTSGU?

In the previous week, IMAC had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 6 mentions for IMAC and 1 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.93 beat IMAC's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IMAC 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, IMAC or LFMDP?

LifeMD has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $15.22M 0.00 -$10.54M -$0.27 N/A LifeMD $191.59M N/A N/A N/A N/A

Is IMAC or LFMDP more profitable?

LifeMD has a net margin of 0.00% compared to IMAC's net margin of -75.40%. LifeMD's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets IMAC -75.40% -52.17% -34.51% LifeMD N/A N/A N/A

Which has preferable valuation & earnings, NIVFW or IMAC?

NewGenIvf Group has higher earnings, but lower revenue than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NewGenIvf Group $4.73M N/A N/A N/A N/A IMAC $15.22M 0.00 -$10.54M -$0.27 N/A

Is NIVFW or IMAC more profitable?

NewGenIvf Group has a net margin of 0.00% compared to IMAC's net margin of -75.40%. NewGenIvf Group's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets NewGenIvf Group N/A N/A N/A IMAC -75.40% -52.17% -34.51%

Does the media prefer NIVFW or IMAC?

In the previous week, IMAC had 3 more articles in the media than NewGenIvf Group. MarketBeat recorded 6 mentions for IMAC and 3 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 0.62 beat IMAC's score of 0.10 indicating that NewGenIvf Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewGenIvf Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IMAC 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

IMAC (IMAC) Competitors

$0.0005 0.00 (0.00%)

As of 08/31/2026

Compare

IMAC vs. BACK, AONCW, BTSGU, LFMDP, and NIVFW

Should you buy IMAC stock or one of its competitors? IMAC's main competitors and comparable companies include IMAC (BACK), American Oncology Network (AONCW), BrightSpring Health Services (BTSGU), LifeMD (LFMDP), and NewGenIvf Group (NIVFW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does IMAC compare to IMAC?

IMAC (NASDAQ:BACK) and IMAC (NASDAQ:IMAC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

IMAC has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	N/A	N/A	-325.44%
IMAC	-75.40%	-52.17%	-34.51%

IMAC has higher earnings, but lower revenue than IMAC. IMAC is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$72.05K	0.03	-$9.42M	-$3.12	N/A
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A

IMAC has a beta of 1.78, meaning that its stock price is 78% more volatile than the broader market. Comparatively, IMAC has a beta of -0.88, meaning that its stock price is 188% less volatile than the broader market.

5.8% of IMAC shares are held by institutional investors. Comparatively, 24.3% of IMAC shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Comparatively, 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, IMAC had 4 more articles in the media than IMAC. MarketBeat recorded 6 mentions for IMAC and 2 mentions for IMAC. IMAC's average media sentiment score of 0.42 beat IMAC's score of 0.10 indicating that IMAC is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IMAC	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IMAC	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

IMAC beats IMAC on 8 of the 13 factors compared between the two stocks.

How does IMAC compare to American Oncology Network?

IMAC (NASDAQ:IMAC) and American Oncology Network (NASDAQ:AONCW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

American Oncology Network has a net margin of 0.00% compared to IMAC's net margin of -75.40%. American Oncology Network's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	-75.40%	-52.17%	-34.51%
American Oncology Network	N/A	N/A	N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

American Oncology Network has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A
American Oncology Network	$1.34B	N/A	N/A	N/A	N/A

In the previous week, IMAC had 6 more articles in the media than American Oncology Network. MarketBeat recorded 6 mentions for IMAC and 0 mentions for American Oncology Network. IMAC's average media sentiment score of 0.10 beat American Oncology Network's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company	Overall Sentiment
IMAC	Neutral
American Oncology Network	Neutral

Summary

IMAC and American Oncology Network tied by winning 4 of the 8 factors compared between the two stocks.

How does IMAC compare to BrightSpring Health Services?

IMAC (NASDAQ:IMAC) and BrightSpring Health Services (NASDAQ:BTSGU) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A
BrightSpring Health Services	$14.37B	N/A	N/A	N/A	N/A

In the previous week, IMAC had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 6 mentions for IMAC and 1 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.93 beat IMAC's score of 0.10 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IMAC	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has a net margin of 0.00% compared to IMAC's net margin of -75.40%. BrightSpring Health Services' return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	-75.40%	-52.17%	-34.51%
BrightSpring Health Services	N/A	N/A	N/A

Summary

BrightSpring Health Services beats IMAC on 6 of the 9 factors compared between the two stocks.

How does IMAC compare to LifeMD?

IMAC (NASDAQ:IMAC) and LifeMD (NASDAQ:LFMDP) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

In the previous week, IMAC had 5 more articles in the media than LifeMD. MarketBeat recorded 6 mentions for IMAC and 1 mentions for LifeMD. LifeMD's average media sentiment score of 1.43 beat IMAC's score of 0.10 indicating that LifeMD is being referred to more favorably in the news media.

Company	Overall Sentiment
IMAC	Neutral
LifeMD	Positive

LifeMD has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A
LifeMD	$191.59M	N/A	N/A	N/A	N/A

24.3% of IMAC shares are owned by institutional investors. 10.0% of IMAC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LifeMD has a net margin of 0.00% compared to IMAC's net margin of -75.40%. LifeMD's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	-75.40%	-52.17%	-34.51%
LifeMD	N/A	N/A	N/A

Summary

LifeMD beats IMAC on 5 of the 8 factors compared between the two stocks.

How does IMAC compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVFW) and IMAC (NASDAQ:IMAC) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NewGenIvf Group has a net margin of 0.00% compared to IMAC's net margin of -75.40%. NewGenIvf Group's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
IMAC	-75.40%	-52.17%	-34.51%

In the previous week, IMAC had 3 more articles in the media than NewGenIvf Group. MarketBeat recorded 6 mentions for IMAC and 3 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 0.62 beat IMAC's score of 0.10 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NewGenIvf Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IMAC	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NewGenIvf Group has higher earnings, but lower revenue than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	N/A	N/A	N/A	N/A
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A

Summary

NewGenIvf Group and IMAC tied by winning 4 of the 8 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IMAC vs. The Competition

Export

Metric	IMAC	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13K	$9.84B	$7.13B	$12.69B
Dividend Yield	N/A	2.56%	2.54%	10.96%
P/E Ratio	0.00	34.09	272.61	25.07
Price / Sales	0.00	4.94	618.34	97.76
Price / Cash	N/A	24.48	28.78	36.03
Price / Book	0.00	5.25	11.06	6.25
Net Income	-$10.54M	$308.29M	$3.47B	$348.99M
7 Day Performance	N/A	-1.04%	-0.83%	-2.41%
1 Month Performance	N/A	0.24%	7.15%	2.95%
1 Year Performance	N/A	13.89%	24.73%	13.70%

IMAC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IMAC IMAC	N/A	$0.00 flat	N/A	-99.3%	$13K	$15.22M	N/A	106
BACK IMAC	N/A	$0.00 flat	N/A	-99.3%	$2K	$72.05K	N/A	180	High Trading Volume
AONCW American Oncology Network	N/A	$0.00 flat	N/A	N/A	$0.00	$1.34B	N/A	1,525
BTSGU BrightSpring Health Services	N/A	$202.19 flat	N/A	+135.9%	$0.00	$14.37B	N/A	35,000	Gap Up
LFMDP LifeMD	N/A	$23.35 +0.3%	N/A	+0.9%	$0.00	$191.59M	N/A	230	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IMAC) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IMAC (IMAC) Competitors

IMAC vs. BACK, AONCW, BTSGU, LFMDP, and NIVFW

How does IMAC compare to IMAC?

Summary

How does IMAC compare to American Oncology Network?

Summary

How does IMAC compare to BrightSpring Health Services?

Summary

How does IMAC compare to LifeMD?

Summary

How does IMAC compare to NewGenIvf Group?

Summary

Media Sentiment Over Time

IMAC vs. The Competition

IMAC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IMAC (IMAC) Competitors

IMAC vs. BACK, AONCW, BTSGU, LFMDP, and NIVFW

How does IMAC compare to IMAC?

Is BACK or IMAC more profitable?

Which has better earnings & valuation, BACK or IMAC?

Which has more volatility and risk, BACK or IMAC?

Do insiders and institutionals hold more shares of BACK or IMAC?

Does the media refer more to BACK or IMAC?

Summary

How does IMAC compare to American Oncology Network?

Is IMAC or AONCW more profitable?

Do insiders and institutionals hold more shares of IMAC or AONCW?

Which has better earnings and valuation, IMAC or AONCW?

Does the media favor IMAC or AONCW?

Summary

How does IMAC compare to BrightSpring Health Services?

Do analysts rate IMAC or BTSGU?

Do insiders & institutionals have more ownership in IMAC or BTSGU?

Which has better earnings & valuation, IMAC or BTSGU?

Does the media refer more to IMAC or BTSGU?

Is IMAC or BTSGU more profitable?

Summary

How does IMAC compare to LifeMD?

Does the media prefer IMAC or LFMDP?

Which has better earnings & valuation, IMAC or LFMDP?

Do insiders and institutionals have more ownership in IMAC or LFMDP?

Is IMAC or LFMDP more profitable?

Summary

How does IMAC compare to NewGenIvf Group?

Do insiders and institutionals have more ownership in NIVFW or IMAC?

Is NIVFW or IMAC more profitable?

Does the media prefer NIVFW or IMAC?

Which has preferable valuation & earnings, NIVFW or IMAC?

Summary

Media Sentiment Over Time

IMAC vs. The Competition

IMAC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools